Oxoid Legionella BCYE Growth Supplement, For 500 ml of medium, SR0110C, packaged 10 vials/box, lyophilized. The firm name on the label is Oxoid Ltd., Basingstoke, Hants, England. The product is used for the isolation of Legionella species from clinical and environmental samples. When the product is added to CYE Agar base, it stabilizes pH and provides essential growth factors for the isolation of the Legionella spp.
Published March 5, 2014 · Recall initiated: January 24, 2014
Summary
FDA records medical device Class II recall Z-1112-2014, published March 5, 2014 and initiated January 24, 2014. Recalling firm: Remel Inc; Status: Terminated; Reported quantity: 44/10/500-ml. vial boxes; Lot: Lot 1380784, Exp. 31Aug2015, and Lot 1367905, Exp. 31Jul2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The product may contain high levels of microbial contamination
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Remel Inc
- Distributor
- US Distribution including Puerto Rico and the states of FL, IL, MA, ME, MI, and PA.
- Lot
- Lot 1380784, Exp. 31Aug2015, and Lot 1367905, Exp. 31Jul2015
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAThermo SCIENTIFIC, Sensititre STP6F, Gram Negative IVD ASTDecember 14, 2022
- FDAThio Med w/Dex, Hem, Vit K (5ml) 100/PK Product Usage; Recommended for use in qualitative procedures as aMay 29, 2019
- FDAThio Med w/Dex, Hemin, Vit K (5ml) 20/PK Product Usage: Recommended for use in qualitative procedures as aMay 29, 2019
- FDABlood Agar (TSA w/ 5% Sheep Blood) Plate, For In Vitro Diagnostic Use, Remel, Lenexa, KS 66215 Product Usage:May 3, 2017
- FDAcobas® PCR Urine Kit 100 PKT IVD cobas® PCR Female Swab Kit 100 PKT IVD cobas® PCR media 100T IVD cobas® PCRMarch 5, 2014
- FDAPREMIER CARE RECLINER 5570 with Urethane armrests, Multiple side-table options, 3 position lock-bar, FullyMarch 5, 2014
Questions about this recall
Was Oxoid Legionella BCYE Growth Supplement, For 500 ml of medium, SR0110C, packaged 10 vials/box, lyophilized. The firm name on the label is Oxoid Ltd., Basingstoke, Hants, England. The product is used for the isolation of Legionella species from clinical and environmental samples. When the product is added to CYE Agar base, it stabilizes pH and provides essential growth factors for the isolation of the Legionella spp. recalled?
Yes. FDA published recall Z-1112-2014 on March 5, 2014. Reported hazard: The product may contain high levels of microbial contamination
What should I do if I have this product?
Voluntary: Firm initiated · Letter